Spotlight on Antibodies

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month in June, we'll highlight the era of AI-driven antibody discovery. References: https://finance.yahoo.com/sectors/healthcare/articles/ai-antibody-discovery-market-research-080100551.html https://pmc.ncbi.nlm.nih.gov/articles/PMC12298131/#B9-pharmaceuticals-18-00981 https://w...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month in May, we'll highlight the future of VHH technology, chemical conjugation in antibody therapeutics, and emerging trends in antibody characterization. References: https://www.tandfonline.com/doi/full/10.1080/19420862.2025.2516676 https://academic.oup.com/peds/article/doi/1...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month, in April, we'll highlight ATP-dependent switch antibodies, the throughput-quality gap in antibody discovery, and multiple myeloma antibody treatments. References:    https://link.springer.com/article/10.1007/s40259-025-00752-y https://www.sciencedirect.com/science/article...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month in March, we'll highlight antibody allostery, trends in developability, and anti-IgE therapeutics.  References: https://www.sciencedirect.com/science/article/abs/pii/S0734975024001769 https://www.tandfonline.com/doi/full/10.1080/19420862.2017.1367074#abstract https://ww...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month in February, we'll highlight radioantibodies, antibody-cytokine fusion proteins, and conditionally active antibodies. References: https://www.mdpi.com/2072-6694/17/21/3412 https://www.sciencedirect.com/science/article/abs/pii/S0001299896800201?via%3Dihub https://swissro...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This month in January, we'll do a deep dive into last year's novel antibody drugs, G protein-coupled receptors, and fusion proteins. References: https://www.biointron.com/antibody-industry-trends/q4-2025-biointron-antibody-industry-insights-report.html https://www.cell.com/tre...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This December, we'll highlight the antibody startup ecosystem, microfluidic strategies driving next-generation antibody discovery, and the landscape of psoriasis treatment. References: https://www.mdpi.com/2079-6374/15/7/409 https://www.tandfonline.com/doi/full/10.1080/19420862.2025....

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This November, we'll highlight how non-canonical antibodies are reshaping immunotherapy, combination antibody therapies, and T cell exhaustion. References: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1723343/full https://www.tandfonline.com/doi/10.1080...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This October, we'll highlight advances in antibody design with AI, crossing the BBB, and universal antibodies.  References: https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-025-00764-4 https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1637602...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This September we'll highlight recent approvals in biosimilar drugs, conjugate linker designs, and discovery platform advances. References https://bmcimmunol.biomedcentral.com/articles/10.1186/s12865-025-00693-9 https://pmc.ncbi.nlm.nih.gov/articles/PMC12185665/ https://www.prnewswir...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This August , we highlight drug advances in autoimmune and infectious diseases, as well as next-generation immune cell engagers. References: Pelkas, C., Franke, K. B., Vincent, F. B., & Rischmueller, M. (2025). Novel therapies in Sjögren’s disease: A systematic review of the literatu...

Spotlight on Antibodies is a podcast from ⁠Biointron⁠ , where we bring you the latest antibody industry trends. This July, recent research includes computational tools for nanodiscs, antibody-drug conjugate (ADC) development, and antibody-antigen research. References: Yao, X., & Thomson, C. A. (2025). Review: Membrane protein nanodiscs for antibody discovery. Current Opinion in Structural Biol...

Spotlight on Antibodies is a podcast from Biointron , where we bring you the latest antibody industry trends. This June, recent research includes VHH antibodies, antibody-drug conjugates in oncology, and antibody engineering as a countermeasure to drug resistance.

Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This May, top news includes BCMA-Targeted Therapies, Multifunctional (Natural Killer Cell Engagers), and Engineering IgE Antibodies.

Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This April, top news includes Fc engineering, FcRn inhibitors, and Tregitopes.

Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This March, top news includes ion channel and GPCR-driven diseases, affinity maturation, and a look back at SARS-CoV-2, 5 years on.

Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This February, top news includes novel antibodies to treat obesity, hereditary angioedema, and B cells.

Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends.  This January, top news includes glycoengineering, anti-malarial antibodies, and PROTACs.